Loading…

Urinary Symptoms Associated with Human T-Cell Lymphotropic Virus Type I Infection: Evidence of Urinary Manifestations in Large Group of HTLV-I Carriers

Objectives To describe the frequency of urologic manifestations in human T-cell lymphotropic virus type I (HTLV-I) seropositive individuals from Salvador and other cities in Bahia, Brazil, with or without clinical HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Methods A total o...

Full description

Saved in:
Bibliographic Details
Published in:Urology (Ridgewood, N.J.) N.J.), 2007-05, Vol.69 (5), p.813-818
Main Authors: Castro, Néviton M, Rodrigues, Waldyr, Freitas, Daniel M, Muniz, André, Oliveira, Paulo, Carvalho, Edgar M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-e3dc6c19d175b3da572232b567f01135dfe9ff077c01e723a1f7ceaf08ba27333
cites cdi_FETCH-LOGICAL-c465t-e3dc6c19d175b3da572232b567f01135dfe9ff077c01e723a1f7ceaf08ba27333
container_end_page 818
container_issue 5
container_start_page 813
container_title Urology (Ridgewood, N.J.)
container_volume 69
creator Castro, Néviton M
Rodrigues, Waldyr
Freitas, Daniel M
Muniz, André
Oliveira, Paulo
Carvalho, Edgar M
description Objectives To describe the frequency of urologic manifestations in human T-cell lymphotropic virus type I (HTLV-I) seropositive individuals from Salvador and other cities in Bahia, Brazil, with or without clinical HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Methods A total of 218 HTLV-I seropositive subjects referred from blood banks or neurologic clinics were admitted to the HTLV-I multidisciplinary outpatient clinic from January 2001 to April 2004. They were assessed using a standardized questionnaire to determine urinary complaints and quality of life. Neurologic impairment was established using the Expanded Disability Status Scale (EDSS). HAM/TSP was considered as an EDSS score of 2 or greater. Results Nocturia (35.8%) was the most frequent finding, followed by incontinence (29.8%), urgency (25.2%), frequency (22.0%), and dysuria (15.6%). Differences were found between individuals with an EDSS score of 0 and those with an EDSS score greater than 0 but less than 2 regarding frequency, nocturia, urgency, urinary loss of any degree, and quality of life. Dysuria and great or total urinary loss were more frequent among those with severe HAM/TSP (EDSS score greater than 6). Conclusions Even HTLV-I subjects considered not to have HAM/TSP may have prominent urinary findings already present. Urologic manifestations, including nocturia and urinary loss, might be early manifestations of neurologic disease in those with HTLV-I.
doi_str_mv 10.1016/j.urology.2007.01.052
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70476078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0090429507001161</els_id><sourcerecordid>70476078</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-e3dc6c19d175b3da572232b567f01135dfe9ff077c01e723a1f7ceaf08ba27333</originalsourceid><addsrcrecordid>eNqFkkGP0zAQhSMEYsvCTwD5xC1h7NRxwwG0qpZtpSIO292r5TrjXZfEDnayKL-Ev4ujFiFx4eTLN2_83psse0uhoECrD8diDL71D1PBAEQBtADOnmULypnI67rmz7MFQA35ktX8InsV4xEAqqoSL7MLKpYrVlNYZL_ugnUqTOR26vrBd5Fcxei1VQM25KcdHslm7JQj-3yNbUt2iXr0Q_C91eTehjGS_dQj2ZKtM6gH691Hcv1kG3QaiTfkj_xX5azBOKgZicQ6slPhAclN8GM_g5v97j7fkrUKwWKIr7MXRrUR35zfy-zuy_V-vcl3326266tdrpcVH3IsG11pWjdU8EPZKC4YK9mBV8IApSVvDNbGgBAaKApWKmqERmVgdVBMlGV5mb0_6fbB_xjTB2Vno05WlUM_RilgKSoQqwTyE6iDjzGgkX2wXbImKci5EXmU50bk3IgEKlMjae7decF46LD5O3WuIAGfTwAmm0_Ju4zazvE1NqREZePtf1d8-kdBt9ZZrdrvOGE8-jG4lKGkMjIJ8nY-i_kqQEAKqaLlb00ntkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70476078</pqid></control><display><type>article</type><title>Urinary Symptoms Associated with Human T-Cell Lymphotropic Virus Type I Infection: Evidence of Urinary Manifestations in Large Group of HTLV-I Carriers</title><source>ScienceDirect Journals</source><creator>Castro, Néviton M ; Rodrigues, Waldyr ; Freitas, Daniel M ; Muniz, André ; Oliveira, Paulo ; Carvalho, Edgar M</creator><creatorcontrib>Castro, Néviton M ; Rodrigues, Waldyr ; Freitas, Daniel M ; Muniz, André ; Oliveira, Paulo ; Carvalho, Edgar M</creatorcontrib><description>Objectives To describe the frequency of urologic manifestations in human T-cell lymphotropic virus type I (HTLV-I) seropositive individuals from Salvador and other cities in Bahia, Brazil, with or without clinical HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Methods A total of 218 HTLV-I seropositive subjects referred from blood banks or neurologic clinics were admitted to the HTLV-I multidisciplinary outpatient clinic from January 2001 to April 2004. They were assessed using a standardized questionnaire to determine urinary complaints and quality of life. Neurologic impairment was established using the Expanded Disability Status Scale (EDSS). HAM/TSP was considered as an EDSS score of 2 or greater. Results Nocturia (35.8%) was the most frequent finding, followed by incontinence (29.8%), urgency (25.2%), frequency (22.0%), and dysuria (15.6%). Differences were found between individuals with an EDSS score of 0 and those with an EDSS score greater than 0 but less than 2 regarding frequency, nocturia, urgency, urinary loss of any degree, and quality of life. Dysuria and great or total urinary loss were more frequent among those with severe HAM/TSP (EDSS score greater than 6). Conclusions Even HTLV-I subjects considered not to have HAM/TSP may have prominent urinary findings already present. Urologic manifestations, including nocturia and urinary loss, might be early manifestations of neurologic disease in those with HTLV-I.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2007.01.052</identifier><identifier>PMID: 17482910</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Blotting, Western ; Brazil - epidemiology ; Carrier State - diagnosis ; Carrier State - epidemiology ; Carrier State - virology ; Cohort Studies ; Comorbidity ; Dysuria - epidemiology ; Dysuria - virology ; Female ; HTLV-I Infections - diagnosis ; HTLV-I Infections - epidemiology ; Human T-lymphotropic virus 1 - isolation &amp; purification ; Humans ; Incidence ; Male ; Middle Aged ; Nocturia - epidemiology ; Nocturia - virology ; Odds Ratio ; Probability ; Prognosis ; Retrospective Studies ; Serologic Tests ; Severity of Illness Index ; Sex Distribution ; Urination Disorders - diagnosis ; Urination Disorders - epidemiology ; Urology</subject><ispartof>Urology (Ridgewood, N.J.), 2007-05, Vol.69 (5), p.813-818</ispartof><rights>Elsevier Inc.</rights><rights>2007 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-e3dc6c19d175b3da572232b567f01135dfe9ff077c01e723a1f7ceaf08ba27333</citedby><cites>FETCH-LOGICAL-c465t-e3dc6c19d175b3da572232b567f01135dfe9ff077c01e723a1f7ceaf08ba27333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17482910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castro, Néviton M</creatorcontrib><creatorcontrib>Rodrigues, Waldyr</creatorcontrib><creatorcontrib>Freitas, Daniel M</creatorcontrib><creatorcontrib>Muniz, André</creatorcontrib><creatorcontrib>Oliveira, Paulo</creatorcontrib><creatorcontrib>Carvalho, Edgar M</creatorcontrib><title>Urinary Symptoms Associated with Human T-Cell Lymphotropic Virus Type I Infection: Evidence of Urinary Manifestations in Large Group of HTLV-I Carriers</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>Objectives To describe the frequency of urologic manifestations in human T-cell lymphotropic virus type I (HTLV-I) seropositive individuals from Salvador and other cities in Bahia, Brazil, with or without clinical HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Methods A total of 218 HTLV-I seropositive subjects referred from blood banks or neurologic clinics were admitted to the HTLV-I multidisciplinary outpatient clinic from January 2001 to April 2004. They were assessed using a standardized questionnaire to determine urinary complaints and quality of life. Neurologic impairment was established using the Expanded Disability Status Scale (EDSS). HAM/TSP was considered as an EDSS score of 2 or greater. Results Nocturia (35.8%) was the most frequent finding, followed by incontinence (29.8%), urgency (25.2%), frequency (22.0%), and dysuria (15.6%). Differences were found between individuals with an EDSS score of 0 and those with an EDSS score greater than 0 but less than 2 regarding frequency, nocturia, urgency, urinary loss of any degree, and quality of life. Dysuria and great or total urinary loss were more frequent among those with severe HAM/TSP (EDSS score greater than 6). Conclusions Even HTLV-I subjects considered not to have HAM/TSP may have prominent urinary findings already present. Urologic manifestations, including nocturia and urinary loss, might be early manifestations of neurologic disease in those with HTLV-I.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Blotting, Western</subject><subject>Brazil - epidemiology</subject><subject>Carrier State - diagnosis</subject><subject>Carrier State - epidemiology</subject><subject>Carrier State - virology</subject><subject>Cohort Studies</subject><subject>Comorbidity</subject><subject>Dysuria - epidemiology</subject><subject>Dysuria - virology</subject><subject>Female</subject><subject>HTLV-I Infections - diagnosis</subject><subject>HTLV-I Infections - epidemiology</subject><subject>Human T-lymphotropic virus 1 - isolation &amp; purification</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nocturia - epidemiology</subject><subject>Nocturia - virology</subject><subject>Odds Ratio</subject><subject>Probability</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Serologic Tests</subject><subject>Severity of Illness Index</subject><subject>Sex Distribution</subject><subject>Urination Disorders - diagnosis</subject><subject>Urination Disorders - epidemiology</subject><subject>Urology</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkkGP0zAQhSMEYsvCTwD5xC1h7NRxwwG0qpZtpSIO292r5TrjXZfEDnayKL-Ev4ujFiFx4eTLN2_83psse0uhoECrD8diDL71D1PBAEQBtADOnmULypnI67rmz7MFQA35ktX8InsV4xEAqqoSL7MLKpYrVlNYZL_ugnUqTOR26vrBd5Fcxei1VQM25KcdHslm7JQj-3yNbUt2iXr0Q_C91eTehjGS_dQj2ZKtM6gH691Hcv1kG3QaiTfkj_xX5azBOKgZicQ6slPhAclN8GM_g5v97j7fkrUKwWKIr7MXRrUR35zfy-zuy_V-vcl3326266tdrpcVH3IsG11pWjdU8EPZKC4YK9mBV8IApSVvDNbGgBAaKApWKmqERmVgdVBMlGV5mb0_6fbB_xjTB2Vno05WlUM_RilgKSoQqwTyE6iDjzGgkX2wXbImKci5EXmU50bk3IgEKlMjae7decF46LD5O3WuIAGfTwAmm0_Ju4zazvE1NqREZePtf1d8-kdBt9ZZrdrvOGE8-jG4lKGkMjIJ8nY-i_kqQEAKqaLlb00ntkw</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Castro, Néviton M</creator><creator>Rodrigues, Waldyr</creator><creator>Freitas, Daniel M</creator><creator>Muniz, André</creator><creator>Oliveira, Paulo</creator><creator>Carvalho, Edgar M</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>Urinary Symptoms Associated with Human T-Cell Lymphotropic Virus Type I Infection: Evidence of Urinary Manifestations in Large Group of HTLV-I Carriers</title><author>Castro, Néviton M ; Rodrigues, Waldyr ; Freitas, Daniel M ; Muniz, André ; Oliveira, Paulo ; Carvalho, Edgar M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-e3dc6c19d175b3da572232b567f01135dfe9ff077c01e723a1f7ceaf08ba27333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Blotting, Western</topic><topic>Brazil - epidemiology</topic><topic>Carrier State - diagnosis</topic><topic>Carrier State - epidemiology</topic><topic>Carrier State - virology</topic><topic>Cohort Studies</topic><topic>Comorbidity</topic><topic>Dysuria - epidemiology</topic><topic>Dysuria - virology</topic><topic>Female</topic><topic>HTLV-I Infections - diagnosis</topic><topic>HTLV-I Infections - epidemiology</topic><topic>Human T-lymphotropic virus 1 - isolation &amp; purification</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nocturia - epidemiology</topic><topic>Nocturia - virology</topic><topic>Odds Ratio</topic><topic>Probability</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Serologic Tests</topic><topic>Severity of Illness Index</topic><topic>Sex Distribution</topic><topic>Urination Disorders - diagnosis</topic><topic>Urination Disorders - epidemiology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castro, Néviton M</creatorcontrib><creatorcontrib>Rodrigues, Waldyr</creatorcontrib><creatorcontrib>Freitas, Daniel M</creatorcontrib><creatorcontrib>Muniz, André</creatorcontrib><creatorcontrib>Oliveira, Paulo</creatorcontrib><creatorcontrib>Carvalho, Edgar M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castro, Néviton M</au><au>Rodrigues, Waldyr</au><au>Freitas, Daniel M</au><au>Muniz, André</au><au>Oliveira, Paulo</au><au>Carvalho, Edgar M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urinary Symptoms Associated with Human T-Cell Lymphotropic Virus Type I Infection: Evidence of Urinary Manifestations in Large Group of HTLV-I Carriers</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>69</volume><issue>5</issue><spage>813</spage><epage>818</epage><pages>813-818</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><abstract>Objectives To describe the frequency of urologic manifestations in human T-cell lymphotropic virus type I (HTLV-I) seropositive individuals from Salvador and other cities in Bahia, Brazil, with or without clinical HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Methods A total of 218 HTLV-I seropositive subjects referred from blood banks or neurologic clinics were admitted to the HTLV-I multidisciplinary outpatient clinic from January 2001 to April 2004. They were assessed using a standardized questionnaire to determine urinary complaints and quality of life. Neurologic impairment was established using the Expanded Disability Status Scale (EDSS). HAM/TSP was considered as an EDSS score of 2 or greater. Results Nocturia (35.8%) was the most frequent finding, followed by incontinence (29.8%), urgency (25.2%), frequency (22.0%), and dysuria (15.6%). Differences were found between individuals with an EDSS score of 0 and those with an EDSS score greater than 0 but less than 2 regarding frequency, nocturia, urgency, urinary loss of any degree, and quality of life. Dysuria and great or total urinary loss were more frequent among those with severe HAM/TSP (EDSS score greater than 6). Conclusions Even HTLV-I subjects considered not to have HAM/TSP may have prominent urinary findings already present. Urologic manifestations, including nocturia and urinary loss, might be early manifestations of neurologic disease in those with HTLV-I.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17482910</pmid><doi>10.1016/j.urology.2007.01.052</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2007-05, Vol.69 (5), p.813-818
issn 0090-4295
1527-9995
language eng
recordid cdi_proquest_miscellaneous_70476078
source ScienceDirect Journals
subjects Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Blotting, Western
Brazil - epidemiology
Carrier State - diagnosis
Carrier State - epidemiology
Carrier State - virology
Cohort Studies
Comorbidity
Dysuria - epidemiology
Dysuria - virology
Female
HTLV-I Infections - diagnosis
HTLV-I Infections - epidemiology
Human T-lymphotropic virus 1 - isolation & purification
Humans
Incidence
Male
Middle Aged
Nocturia - epidemiology
Nocturia - virology
Odds Ratio
Probability
Prognosis
Retrospective Studies
Serologic Tests
Severity of Illness Index
Sex Distribution
Urination Disorders - diagnosis
Urination Disorders - epidemiology
Urology
title Urinary Symptoms Associated with Human T-Cell Lymphotropic Virus Type I Infection: Evidence of Urinary Manifestations in Large Group of HTLV-I Carriers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A59%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urinary%20Symptoms%20Associated%20with%20Human%20T-Cell%20Lymphotropic%20Virus%20Type%20I%20Infection:%20Evidence%20of%20Urinary%20Manifestations%20in%20Large%20Group%20of%20HTLV-I%20Carriers&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Castro,%20N%C3%A9viton%20M&rft.date=2007-05-01&rft.volume=69&rft.issue=5&rft.spage=813&rft.epage=818&rft.pages=813-818&rft.issn=0090-4295&rft.eissn=1527-9995&rft_id=info:doi/10.1016/j.urology.2007.01.052&rft_dat=%3Cproquest_cross%3E70476078%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-e3dc6c19d175b3da572232b567f01135dfe9ff077c01e723a1f7ceaf08ba27333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70476078&rft_id=info:pmid/17482910&rfr_iscdi=true